CAPN2 and interstitial lung disease: In this study, we used our previously developed efficient and affordable Exo-CMDS system [23] and high-throughput proteomic sequencing to identify and validate three circulating exosomal protein (KL-6, CAPN2, SP-B) for ILD in two sample sets of > 600 subjects combined.